Bausch + Lomb Corporation filed an amendment to report that Thomas J. Appio succeeded Brent Saunders as Chairman of the Board effective August 10, 2026, while Mr. Saunders continues serving on the board. The company also appointed Robert Chersi, Laurence Paul, M.D., and Barbara Trebbi to its committees with specific chair roles: Dr. Paul leads the Nominating and Corporate Governance Committee, Eduardo Alfonso chairs the Science and Technology Committee, and Ms. Trebbi chairs the Talent and Compensation Committee. These changes follow earlier resignations and appointments announced on August 6, 2026. Bausch + Lomb Corporation operates in the healthcare industry, specializing in eye health products including contact lenses and ophthalmic pharmaceuticals.
